{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-21-009299","form_type":"8-K","ticker":"CAPR","cik":"0001133869","company_name":"CAPRICOR THERAPEUTICS, INC.","filed_at":"2021-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.245337+00:00","generated_at":"2026-06-30T02:04:29.176246+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Capricor Therapeutics appoints Karimah Es Sabar to Board of Directors","bullets":["Karimah Es Sabar appointed to Capricor's Board of Directors effective July 23, 2021.","She brings over 35 years of biopharma leadership, drug development, and venture investing experience.","Es Sabar currently serves as CEO and Partner at Quark Venture LP.","She will receive standard non-employee director compensation under Company policies.","Previously held senior roles at CDRD and Sanofi Pasteur; holds degrees in neurochemistry and biochemistry."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-21-009299","json":"https://secwatch.observer/filing/0001558370-21-009299.json","markdown":"https://secwatch.observer/filing/0001558370-21-009299.md","text":"https://secwatch.observer/filing/0001558370-21-009299.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/0001558370-21-009299-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/tmb-20210723x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:04:29.176246+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"283764c73b","claim":"Karimah Es Sabar was elected as Director at CAPRICOR THERAPEUTICS, INC..","evidence_excerpt":"On July 23, 2021, the Board of Directors of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), elected Karimah Es Sabar as a member of the Company’s Board of Directors (the “Board”) effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/0001558370-21-009299-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}